E815
TEAS SECTION 8 & 15 RECEIVED
20/05/2026
Voltar para busca
Dado oficial do USPTO
AVANIA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
AVANIA
ST13
US500000088600290Classe
35, 41, 42, 45
Pedido
88600290
Registro
6071106
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
21/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 41, 42, 45
Data de depósito
30/08/2019
Data de registro
02/06/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/06/2020
Última transação
21/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
02/03/2020
Primeiro uso no comércio
02/03/2020
Código do desenho
4
Tipo de titular
26
Localização do titular
BILTHOVEN, NL
Examinador
OPUTA, CHIOMA N
Unidade examinadora
L30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
EAGLE BIDCO B.V.
AVANIA INVESTMENTS BV
Factory CRO Investments BV
Representantes
Roberto Ledesma Law Office of Roberto Ledesma
Classificação técnica
Classes Nice
Classe 35Classe 41Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of pharmaceuticalmedicalhealthcarelife sciences companies to assist them with clinical researchclinical trials and applications for drugbiologic and device approval; providing independent review of clinical trials for business purposes; Contract research organization (CRO) servicesbusiness management in the field of clinical trialsclinical data management; Medical records coding services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance and other third-party payers; Business consulting services in the field of medical coding in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance and other third-party payers; Providing reimbursement servicesproviding business advice and information relating to reimbursement strategies and support to companies involved in the healthcare field
Classe 41
Contract research organization (CRO) servicescustom writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports
Classe 42
Contract research organization (CRO) servicesmonitoring of clinical trials for drugsbiologics and devices of pharmaceuticalmedicalhealthcarelife sciences companies for quality control purposesclinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areasincluding orthopediccardiovasculardermatologyaesthetics; consulting services in the field of conducting clinical trials in the pharmaceutical industrythe biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the Food and Drug Administration (FDA) by life sciences companies to ensure validity and accuracy; product development for othersproviding implementation services relating to the development and validation of drugsbiologics and medical devices
Classe 45
Providing independent review of clinical trials involving human subjectsreviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; regulatory compliance consulting in the pharmaceuticalmedicalhealthcarelife sciences fields
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/02/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/06/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
24/04/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/04/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
24/04/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/04/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/04/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
24/04/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/01/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/01/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/01/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
20/01/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/03/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/06/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
30/04/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
29/04/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/04/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/04/2020
IUAF
USE AMENDMENT FILED
17/03/2020
EISU
TEAS STATEMENT OF USE RECEIVED
17/03/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
17/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/01/2020
PUBO
PUBLISHED FOR OPPOSITION
21/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2020
ALIE
ASSIGNED TO LIE
13/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
10/12/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/12/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
10/12/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/12/2019
DOCK
ASSIGNED TO EXAMINER
04/12/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/09/2019
NWAP
NEW APPLICATION ENTERED
03/09/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AVANIA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.